Related Articles for PubMed (Select 16542501)

Deciphering cellular states of innate tumor drug responses.

Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Grémy G, Couillault C, Lajémi M, Piatier-Tonneau D, Zaborski P, Eveno E, Auffray C, Imbeaud S.

Genome Biol. 2006;7(3):R19. Epub 2006 Mar 15.

PMID: 16542501 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID: 17993229 [PubMed - indexed for MEDLINE]

Molecular signature for lymphatic metastasis in colorectal carcinomas.

Croner RS, Förtsch T, Brückl WM, Rödel F, Rödel C, Papadopoulos T, Brabletz T, Kirchner T, Sachs M, Behrens J, Klein-Hitpass L, Stürzl M, Hohenberger W, Lausen B.

Ann Surg. 2008 May;247(5):803-10.

PMID: 18438117 [PubMed - indexed for MEDLINE]

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

Györffy B, Surowiak P, Kiesslich O, Denkert C, Schäfer R, Dietel M, Lage H.

Int J Cancer. 2006 Apr 1;118(7):1699-712.

PMID: 16217747 [PubMed - indexed for MEDLINE]

Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, Longley DB, Caldas C, Johnston PG.

Cancer Res. 2006 Mar 1;66(5):2765-77.

PMID: 16510598 [PubMed - indexed for MEDLINE]

Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents.

Jung JJ, Jeung HC, Lee JO, Kim TS, Chung HC, Rha SY.

Oncol Rep. 2007 Sep;18(3):593-9.

PMID: 17671706 [PubMed - indexed for MEDLINE]

Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.

Tempestini A, Caciagli B, Morganti M, Witort E, Nobili S, Papucci L, Schiavone N, Donnini M, Landini I, Lapucci A, Perna F, Lulli M, Mazzei T, Sobrero A, Mini E, Capaccioli S.

Oncol Res. 2005;16(3):143-56.

PMID: 16925115 [PubMed - indexed for MEDLINE]

Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.

Quintieri L, Fantin M, Vizler C.

Adv Exp Med Biol. 2007;593:95-104. Review.

PMID: 17265720 [PubMed - indexed for MEDLINE]

Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.

Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche TJ, Reynolds CP.

J Natl Cancer Inst. 2007 Jul 18;99(14):1107-19. Epub 2007 Jul 10.

PMID: 17623797 [PubMed - indexed for MEDLINE]

10:

Gene signatures developed from patient tumor explants grown in nude mice to predict tumor response to 11 cytotoxic drugs.

Fiebig HH, Schüler J, Bausch N, Hofmann M, Metz T, Korrat A.

Cancer Genomics Proteomics. 2007 May-Jun;4(3):197-209.

PMID: 17878523 [PubMed - indexed for MEDLINE]

11:

Gene expression profiling in chemoresistant variants of three cell lines of different origin.

Johnsson A, Vallon-Christensson J, Strand C, Litman T, Eriksen J.

Anticancer Res. 2005 Jul-Aug;25(4):2661-8.

PMID: 16080509 [PubMed - indexed for MEDLINE]

12:

Pharmacogenomics in colorectal cancer: the first step for individualized-therapy.

Bandrés E, Zárate R, Ramirez N, Abajo A, Bitarte N, Garíia-Foncillas J.

World J Gastroenterol. 2007 Nov 28;13(44):5888-901. Review.

PMID: 17990354 [PubMed - indexed for MEDLINE]

13:

Drug resistance, predictive markers and pharmacogenomics in colorectal cancer.

Longley DB, Allen WL, Johnston PG.

Biochim Biophys Acta. 2006 Dec;1766(2):184-96. Epub 2006 Aug 9. Review.

PMID: 16973289 [PubMed - indexed for MEDLINE]

14:

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.

Hsu DS, Balakumaran BS, Acharya CR, Vlahovic V, Walters KS, Garman K, Anders C, Riedel RF, Lancaster J, Harpole D, Dressman HK, Nevins JR, Febbo PG, Potti A.

J Clin Oncol. 2007 Oct 1;25(28):4350-7.

PMID: 17906199 [PubMed - indexed for MEDLINE]

15:

A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients.

Bandrés E, Malumbres R, Cubedo E, Honorato B, Zarate R, Labarga A, Gabisu U, Sola JJ, García-Foncillas J.

Oncol Rep. 2007 May;17(5):1089-94.

PMID: 17390049 [PubMed - indexed for MEDLINE]

16:

Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.

Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, Guilford PJ, Phillips V, Thompson-Fawcett M, Kasabov N, Toro T, Merrie AE, van Rij A, Yoon HS, McCall JL, Siewert JR, Holzmann B, Reeve AE.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):498-507.

PMID: 17255271 [PubMed - indexed for MEDLINE]

17:

An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.

Isogai A, Nagaya M, Matsuoka H, Watanabe T, Tsukikawa S, Kubota S.

Surgery. 2007 Nov;142(5):741-8.

PMID: 17981195 [PubMed - indexed for MEDLINE]

18:

Whole genome analysis for liver metastasis gene signatures in colorectal cancer.

Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, Lee WS, Kim NK, Chung HC, Rha SY.

Int J Cancer. 2007 Nov 1;121(9):2005-12.

PMID: 17640062 [PubMed - indexed for MEDLINE]